Invention Grant
- Patent Title: Aryl aniline β2 adrenergic receptor agonists
- Patent Title (中): 芳基苯胺β2肾上腺素受体激动剂
-
Application No.: US11805101Application Date: 2007-05-22
-
Publication No.: US07582765B2Publication Date: 2009-09-01
- Inventor: Edmund J. Moran , John R. Jacobsen , Michael R. Leadbetter , Matthew B. Nodwell , Sean G. Trapp , James Aggen , Timothy J. Church
- Applicant: Edmund J. Moran , John R. Jacobsen , Michael R. Leadbetter , Matthew B. Nodwell , Sean G. Trapp , James Aggen , Timothy J. Church
- Applicant Address: US CA South San San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San San Francisco
- Agent Jeffrey A. Hagenah; Roberta P. Saxon
- Main IPC: C07D215/00
- IPC: C07D215/00 ; A01N43/42 ; A01N33/02
Abstract:
The invention provides novel β2 adrenergic receptor agonist compounds of formula (I): wherein R1-R13 and w have any of the values described in the specification. The invention also provides combinations of such compounds and other therapeutic agents, pharmaceutical compositions comprising such compounds and combinations, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Public/Granted literature
- US20070225329A1 Aryl aniline beta2 adrenergic receptor agonists Public/Granted day:2007-09-27
Information query
